The endocannabinoid gene faah2a modulates stress-associated behavior in zebrafish

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• Endocannabinoid system (ECS) neurotransmitters regulate stress responses, crucial for survival and implicated in neuropsychiatric disorders.
• Dysfunction in ECS signaling is linked to stress-related conditions, making it a potential therapeutic target.
• Zebrafish (Danio rerio) offer a conserved model for studying ECS gene function due to genetic similarities with humans.

Purpose of the Study:

• To investigate the expression and function of ECS genes in zebrafish.
• To determine the role of cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase 2a (FAAH2A) in modulating stress-associated behaviors.
• To validate zebrafish as a model for studying ECS in stress and neuropsychiatric disorders.

Main Methods:

• Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) to assess gene expression of ECS enzymes and receptors.
• CRISPR-Cas9 gene editing (transcription activator-like effector nucleases) to create zebrafish mutants for cnr1 and faah2a.
• Behavioral assays measuring locomotor responses to hyperosmotic stress in wild-type and mutant zebrafish.

Main Results:

• Genes encoding endocannabinoid synthesis, degradation enzymes, and receptors (CNR1, FAAH2A) are expressed in zebrafish.
• Zebrafish cnr1 disruption potentiated locomotor activity under stress, consistent with rodent models.
• Zebrafish faah2a disruption attenuated locomotor activity under stress, indicating a novel role for FAAH2 in stress response.

Conclusions:

• Zebrafish possess a conserved endocannabinoid system relevant to stress modulation.
• CNR1 and FAAH2A play distinct roles in regulating behavioral responses to stress.
• Targeting FAAH and FAAH2 offers potential therapeutic avenues for stress-related disorders.